APD
60
5
HCA
75
4
PYPL
43
16
HP
32
4
NOV
39
6
STZ
70
5
OMC
59
2
KEY
37
6
NRG
60
-7
CSX
41
4
AEE
35
-2
CMS
71
4
ORLY
48
4
PH
66
2
HIG
72
2
AEP
62
4
HAL
37
6
FMC
26
3
HSY
54
4
GIS
52
2
APD
60
5
HCA
75
4
PYPL
43
16
HP
32
4
NOV
39
6
STZ
70
5
OMC
59
2
KEY
37
6
NRG
60
-7
CSX
41
4
AEE
35
-2
CMS
71
4
ORLY
48
4
PH
66
2
HIG
72
2
AEP
62
4
HAL
37
6
FMC
26
3
HSY
54
4
GIS
52
2
Financhill
Back

Cabaletta Bio Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
17

CABA
Cabaletta Bio

Last Price:
10.17
Seasonality Move:
30.53%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
148.43
Seasonality Move:
18.05%
Sell
17
Cabaletta Bio (CABA) is a Sell

Is Cabaletta Bio a Buy, Sell or Hold?

  • The current Cabaletta Bio [CABA] share price is $10.17. The Score for CABA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • CABA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $148.43. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CABA Stock Price Chart

What is Cabaletta Bio's stock price today?

  • The Cabaletta Bio share price today is $10.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CABA is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $148.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

CABA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1 Sell
Relative Strength Index (14 RSI): 33.02 Sell
Chaikin Money Flow: 545031 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.68 - 12.58) Sell
Bollinger Bands (100): (13.27 - 22.47) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 48.05 Sell
Chaikin Money Flow: -692560 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (147.03 - 151.85) Sell
Bollinger Bands (100): (143.34 - 172.28) Sell

CABA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.87 Sell
20-day SMA: 11.68 Sell
50-day SMA: 13.86 Sell
200-day SMA: 17.14 Sell
8-day EMA: 10.74 Sell
20-day EMA: 11.62 Sell
50-day EMA: 13.78 Sell
200-day EMA: 15.79 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 149.14 Sell
20-day SMA: 150.06 Sell
50-day SMA: 149.42 Sell
200-day SMA: 167.58 Sell
8-day EMA: 149.04 Sell
20-day EMA: 149.25 Sell
50-day EMA: 150.86 Sell
200-day EMA: 165.73 Sell

Cabaletta Bio Earnings Growth & CABA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.58 per share, and an increase next year of $0.04 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.

Cabaletta Bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):